[Terfenadine compared to clemastine in the treatment of pruriginous cutaneous diseases. Double-blind comparative study]. 1987

A Castro Torres, and L Martín Moreno, and J Jiménez Reyes, and Y Riesgo Bucher

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011759 Pyrrolidines Compounds also known as tetrahydropyridines with general molecular formula (CH2)4NH. Tetrahydropyridine,Tetrahydropyridines
D011897 Random Allocation A process involving chance used in therapeutic trials or other research endeavor for allocating experimental subjects, human or animal, between treatment and control groups, or among treatment groups. It may also apply to experiments on inanimate objects. Randomization,Allocation, Random
D002974 Clemastine A histamine H1 antagonist used as the hydrogen fumarate in hay fever, rhinitis, allergic skin conditions, and pruritus. It causes drowsiness. Meclastine,Mecloprodin,2-(2-(1-(4-Chlorophenyl)-1-phenylethoxy)ethyl)-1-methylpyrrolidine,Clemastine Fumarate,HS-592,Tavegyl,Tavist,HS 592,HS592
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D003876 Dermatitis, Atopic A chronic inflammatory genetically determined disease of the skin marked by increased ability to form reagin (IgE), with increased susceptibility to allergic rhinitis and asthma, and hereditary disposition to a lowered threshold for pruritus. It is manifested by lichenification, excoriation, and crusting, mainly on the flexural surfaces of the elbow and knee. In infants it is known as infantile eczema. Eczema, Atopic,Eczema, Infantile,Neurodermatitis, Atopic,Neurodermatitis, Disseminated,Atopic Dermatitis,Atopic Eczema,Atopic Neurodermatitis,Disseminated Neurodermatitis,Infantile Eczema
D004311 Double-Blind Method A method of studying a drug or procedure in which both the subjects and investigators are kept unaware of who is actually getting which specific treatment. Double-Masked Study,Double-Blind Study,Double-Masked Method,Double Blind Method,Double Blind Study,Double Masked Method,Double Masked Study,Double-Blind Methods,Double-Blind Studies,Double-Masked Methods,Double-Masked Studies,Method, Double-Blind,Method, Double-Masked,Methods, Double-Blind,Methods, Double-Masked,Studies, Double-Blind,Studies, Double-Masked,Study, Double-Blind,Study, Double-Masked
D005260 Female Females
D006634 Histamine H1 Antagonists Drugs that selectively bind to but do not activate histamine H1 receptors, thereby blocking the actions of endogenous histamine. Included here are the classical antihistaminics that antagonize or prevent the action of histamine mainly in immediate hypersensitivity. They act in the bronchi, capillaries, and some other smooth muscles, and are used to prevent or allay motion sickness, seasonal rhinitis, and allergic dermatitis and to induce somnolence. The effects of blocking central nervous system H1 receptors are not as well understood. Antihistamines, Classical,Antihistaminics, Classical,Antihistaminics, H1,Histamine H1 Antagonist,Histamine H1 Receptor Antagonist,Histamine H1 Receptor Antagonists,Histamine H1 Receptor Blockaders,Antagonists, Histamine H1,Antagonists, Histamine H1 Receptor,Antihistamines, Sedating,Blockaders, Histamine H1 Receptor,First Generation H1 Antagonists,H1 Receptor Blockaders,Histamine H1 Blockers,Receptor Blockaders, H1,Antagonist, Histamine H1,Classical Antihistamines,Classical Antihistaminics,H1 Antagonist, Histamine,H1 Antagonists, Histamine,H1 Antihistaminics,Sedating Antihistamines

Related Publications

A Castro Torres, and L Martín Moreno, and J Jiménez Reyes, and Y Riesgo Bucher
December 1985, British journal of clinical pharmacology,
A Castro Torres, and L Martín Moreno, and J Jiménez Reyes, and Y Riesgo Bucher
January 1989, The Journal of international medical research,
A Castro Torres, and L Martín Moreno, and J Jiménez Reyes, and Y Riesgo Bucher
June 1993, Allergie et immunologie,
A Castro Torres, and L Martín Moreno, and J Jiménez Reyes, and Y Riesgo Bucher
January 1992, Journal of investigational allergology & clinical immunology,
A Castro Torres, and L Martín Moreno, and J Jiménez Reyes, and Y Riesgo Bucher
March 1987, Rhinology,
A Castro Torres, and L Martín Moreno, and J Jiménez Reyes, and Y Riesgo Bucher
April 1989, Annals of allergy,
A Castro Torres, and L Martín Moreno, and J Jiménez Reyes, and Y Riesgo Bucher
January 1996, Drugs,
A Castro Torres, and L Martín Moreno, and J Jiménez Reyes, and Y Riesgo Bucher
December 1989, Allergie et immunologie,
A Castro Torres, and L Martín Moreno, and J Jiménez Reyes, and Y Riesgo Bucher
January 1985, Dermatologica,
A Castro Torres, and L Martín Moreno, and J Jiménez Reyes, and Y Riesgo Bucher
July 1988, Annals of allergy,
Copied contents to your clipboard!